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Interleukin-17 (IL-17) is a new pro-inflammatory cytokine involved in immune response and
inflammatory disease. The main source of IL-17 is a subset of CD4+ T-helper cells, but is
also secreted by non-immune cells. The present study analyzes expression of IL-17 in the
time course of acute anti-thy1 glomerulonephritis and the role of IL-17 as a potential link
between inflammation and fibrosis.
Methods
Anti-thy1 glomerulonephritis was induced into male Wistar rats by OX-7 antibody injection.
After that, samples were taken on days 1, 5, 10 (matrix expansion phase), 15 and 20 (reso-
lution phase). PBS-injected animals served as controls. Proteinuria and histological
matrixes score served as the main markers for disease severity. In in vitro experiments,
NRK-52E cells were used. For cytokine expressions, mRNA and protein levels were ana-
lyzed by utilizing RT-PCR, in situ hybridization and immunofluorescence.
Results
Highest IL-17 mRNA-expression (6.50-fold vs. con; p<0.05) was found on day 5 after induc-
tion of anti-thy1 glomerulonephritis along the maximum levels of proteinuria (113 ± 13 mg/d;
p<0.001), histological glomerular-matrix accumulation (82%; p<0.001) and TGF-β1 (2.2-fold;
p<0.05), IL-6 mRNA expression (36-fold; p<0.05). IL-17 protein expression co-localized with
the endothelial cell marker PECAM in immunofluorescence. In NRK-52E cells, co-adminis-
tration of TGF-β1 and IL-6 synergistically up-regulated IL-17 mRNA 4986-fold (p<0.001).
Conclusions
The pro-inflammatory cytokine IL-17 is up-regulated in endothelial cells during the time
course of acute anti-thy1 glomerulonephritis. In vitro, NRK-52E cells secrete IL-17 under
pro-fibrotic and pro-inflammatory conditions.
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Introduction
As shown by the foundation "World Kidney Day", more than 500 million patients pose chronic
kidney diseases due to various underlying immune and non-immune entities [1]. The process
of glomerulonephritis formation and disease progression is complex and involves multiple
interactions between resident cells, infiltrating cells, and their soluble factors. This has already
been well addressed [2–4]. However, the interaction between pro-inflammatory and pro-
fibrotic factors in this process is still not fully understood. In general, acute and chronic glo-
merular disorders are characterized by a three-step sequence of renal damage. This begins with
a deterioration of resident glomerular structures (injury phase). Then, injured resident cells
respond, increasing extracellular matrix production and accumulation (matrix expansion
phase). Finally, the matrix accumulation may resolve (in the resolution phase) but this can also
advance to subsequent nephron destruction (progression phase). Increased extracellular matrix
expansion, in which the cytokine TGF-β1 represents the key mediator of matrix expansion and
fibrosis, correlates with the ongoing loss of kidney function [5].
The cytokine IL-17, together with its IL-17 receptor signaling axis is strikingly different in
sequence and structure from those of other cytokine families [6]. IL-17A and IL-17F, approxi-
mately 55% homologous, are the best-characterized family members of the IL-17 cytokine fam-
ily. These comprise six structurally related isoforms (IL-17 A to F) [7]. Both IL-17A and IL-17F
have been shown to promote the inflammatory pathology of a number of autoimmune diseases
such as rheumatoid arthritis, lupus erythematodes, psoriasis, and asthma [8–11]. The main
source of IL-17 is a subset of CD4+ T-helper cells known as TH17 cells [12]. IL-17-expressing
TH17 cells have been known to play a role in inflammatory diseases [9–11] and in renal
inflammation [13–15]. In addition γδ T-cells [16], natural killer T-cells [17], neutrophils [18–
20], as well as mast cells [21] are known to express IL-17. IL-17 production is induced by a
combination of IL-6 and TGF-β1, and maintained by IL-23 [22–27]. However, IL-17 is also
required for host defense and acts mainly by inducing neutrophil recruitment [28–30]. With
regard to the kidney, IL-17 expression has been shown in tubular epithelial cells in human anti-
body-mediated kidney rejection [31]. In human proximal tubular epithelial cells, in turn, IL-17
has been found to stimulate the expression of the inflammatory factors IL-6, CXCL8 and CCL2
[32].
The aim of this study was to characterize IL-17 expression over the course of acute anti-
thy1 glomerulonephritis, to identify the IL-17 expressing cells, and to elucidate further the IL-
17 / TGF-β1 interaction in renal cells.
Methods
Materials
Unless otherwise indicated, all materials and chemicals were purchased from Sigma Chemical-
Aldrich (Taufkirchen, Germany).
Animals and induction of acute anti-thy1 glomerulonephritis. All animal experiments
were conducted in accordance with good animal practice as defined by FELASA (www.felasa.
eu/guidelines.php) and the national animal welfare body GV-SOLAS (www.gv-solas.de/index.
html). The experiments were approved by our local governmental animal welfare authority
(Landesamt für Gesundheit und Soziales, Berlin, permit number: G0144/06).
Male Wistar rats were obtained from Charles River (Sulzfeld, Germany), fed a normal pro-
tein diet (22% protein; Altromin, Lage, Germany) and housed in a constant-temperature room
with a 12:12-h dark-light cycle. Acute anti-thy1 glomerulonephritis was induced as previously
described. Briefly, monoclonal OX-7 antibody (1 mg/kg body weight in PBS) was injected to
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induce a complement and NO-dependent lysis of mesangial cells [33]. Animal specimens were
obtained on days 1, 5, 10, 15 and 20 after disease induction (n = 6 for each group: 24h, d5, d10,
d15, d20). PBS-injected animals served as controls (con, n = 6).
Urine collection and measurement of renal function. Animals were housed in individual
metabolic cages (Techniplast, Buguggiate, Italy) for urine collection 24 h before the end of
experiment. Urinary protein was measured by using the pyrogallol red technique as previously
described [34]. Proteinuria is expressed as milligrams of protein per 24 h.
Histological examinations. Renal cortical tissue was fixed for 2.5 h in Carnoy´s solution
(acetic acid—methanol—chloroform 10:60:30), followed by a fixation for 12 h in 100% ethanol
and 1 h in xylol. All histological analyses were performed in a blinded fashion. 3-μm sections of
paraffin embedded tissues were stained by using the periodic acid-Schiff (PAS) stain. Glomeru-
lar fibrosis was calculated by a computer-based histomorphometric analysis involving a Zeiss
Axio Imager A.1 light microscope, a PL-A662 video camera, and the Axiovision 4.1 image-
analysis system [34]. The level of glomerular matrix expansion was analyzed by calculating the
relative degree of mesangial-matrix-occupying area (in percent) of 15 glomeruli from every rat
[35].
For in situ hybridization, 4% formalin-fixed tissue samples were embedded in paraffin and
cut into 3-μm sections, dewaxed, rehydrated, incubated with proteinase K (Dako, Glostrup,
Denmark), rinsed twice in PBS, and then post-fixed in 4% (w/v) paraformaldehyde for 5 min.
Antisense RNA probes were prepared from cDNA and labeled with digoxigenin (DIG) by
using a DIG RNA labeling kit (Roche, Mannheim, Germany). After washing in PBS and incu-
bation for 10 min in 0.1 M triethanol acetic anhydride pH 8, the sections were again dehy-
drated and hybridized at 37°C overnight with a DIG-labeled RNA probe specific to rat IL-17A
in 50% formamide, 10 μg/ml sheared salmon sperm DNA (Ambion, Kaufungen, Germany), 5x
Denhardt´s solution, 5x SCC, 0.1% SDS, and 5 μg/ml heparin. Subsequently, tissues were
washed for 30 min three times with 4x SCC at 37°C, and then for 20 min twice with 0.1x SCC
at room temperature and finally once with PBS. Hybridized DIG was detected using an anti-
DIG/HRP-labeled antibody (Dako, Glostrup, Denmark) at a concentration or 1:2000 for 2 h at
37°C followed by reaction with the SigmaFast™ BCIP/NBT- HRP substrate according to the
manufacture's protocol.
For immunofluorescence analysis a cold-light source (HAL 100FluoArc, Carl Zeiss Vision,
Munich, Germany) was employed, and detection of IL-17 and TGF-β1 was carried out on 3-
μm sections of Carnoy's fixed kidney tissue. Sections were rehydrated followed by two min of
pressure cooking with EDTA-buffer (10 mM EDTA, 0.05% Tween 20, pH 9.0). After blocking
by 20% BSA (in aqua dest), tissues were incubated for 1 h with specific goat anti-rat IL-17
1:200, rabbit anti-rat TGF-β1 1:200 and goat anti- rat PECAM-1 antibody at 1:200 (all Santa
Cruz, Heidelberg, Germany) or rabbit anti-rat Synaptopodin also at 1:200 (abcam). Subse-
quently, slides were washed using 1x TBS (three times for 5 min each) and incubated with the
secondary fluorochrome-linked antibody Alexa Fluor 488 or 568 (Invitrogen, Eugene, Oregon,
USA) for 30 min. Prior to nuclear staining with 4´-6´-diamidino-2´-phenylindol (DAPI),
(Invitrogen, Eugene, Oregon, USA) for 30 s, slides were washed 3 times for 5 min each with 1x
TBS. Finally, tissue sections were covered with Fluoromount-G (Southern Biotech, Birming-
ham, USA) and stored at -20°C until examination. For a list of the primary antibodies used, see
Table 1.
RNA preparation and RT-qPCR. The gene expression level of IL-17, TGF-β1, IL-6 and
GAPDH/ β-actin was quantitated by Q-PCR as previously reported. Briefly, total RNA were
isolated by using the Trizol™ reagent (Invitrogen, Darmstadt, Germany) according to the man-
ufacturer’s instructions. After isolation from each sample, 1 μg of total mRNA was used for
cDNA synthesis by reverse transcription using the RNA PCR Core kit (Roche, Applied
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Biosystems, New Jersey, USA). Predesigned primers specific for the target were purchased
from TIB MOLBIOL (Berlin, Germany). Each reaction consisted of 10 μl containing 2x Master
Mix (quantifast SYBR Green PCR kit; Qiagen, Hilden, Germany), primer and cDNA. Amplifi-
cation conditions consisted of 50 cycles at 95°C for 10 s, annealing 10 s (for list of temperature,
see Table 2), and incubation at 72°C for 20 s. Amplification and fluorescence measurements
were performed using the Mastercycler1 ep realplexS system (Eppendorf, Hamburg, Ger-
many). mRNA expression was normalized using GAPDH in aGN experiments and β-actin in
cell culture experiments as an endogenous control to correct for differences in the amount of
total RNA originally added to each reaction. For analysis, the relative quantification ΔΔCP
method was used. First, the crossing point (CP) of target gene was subtracted from the CP of
the housekeeping gene. The result of this is the ΔCP value. ΔΔCP was calculated by subtraction
of the ΔCP mean value of controls from the ΔCP of treated samples. The optimal PCR effi-
ciency (E = 2) is represented by a DNA doubling at each cycle. Hence, the expression ratio of
target gene to untreated control is expected to be 2−ΔΔCT [36]. For a list of the primer pairs
used, see Table 2.
Cell culture experiments. The rat proximal tubular cell line NRK-52E was obtained from
DSZM (DSMZ no. ACC 199, Heidelberg, Germany) and grown in DMEM supplemented with
10% fetal calf serum, 100 μg/ml penicillin, 100 μg/ml streptomycin and 2 mM L-glutamine (all
from Biochrom, Berlin, Germany) in an atmosphere of 5% CO2 at 37°C. Cells from passages
5–10 were used. Before treatment, cells underwent 24 h of starvation for cell cycle synchroniza-
tion. To further elucidate TGF-β1, IL-6 and IL-17 mRNA expression, NRK-52E cells were
stimulated by a high glucose content of 25 mM (high glucose, HG) over the time periods indi-
cated. NRK-52E cells incubated with 5 mM glucose, and 20 mMmannose served as an osmotic
control. To mimic conditions in acute anti-thy1 glomerulonephritis, NRK-52E cells were co-
stimulated by using 10 ng/ml of IL-6 and 5 ng/ml TGF-β1. The specific inhibitor of TGF-β
superfamily activin receptor-like kinase (ALK) SB 431542 (10 μM) was used to further charac-
terize the TGF-β1/ IL-17 network in NRK-52E cells. In all experiments, native untreated NRK-
52E cells served as control.
Analysis of TGF-β1, IL-6 and IL-17 mRNA employed RT-PCR as described above. For
immunofluorescence staining, NRK-52E cells under various conditions were fixed on slides
Table 1. Antibodies used for immunohistochemistry and immunofluorescence.
Antigen Manufacturer Host Isotype Catalog No.
IL-17 Santa Cruz Biotechnology, Inc., CA, USA goat IgG SC6077
TGF-β1 Santa Cruz Biotechnology, Inc., CA, USA rabbit IgG SC146
PCAM-1 Santa Cruz Biotechnology, Inc., CA, USA goat IgG SC17019
Synaptopodin Abcam, MA, USA rabbit IgG ab101883
DIG DAKO, Glostrup, Denmark rabbit IgG P5104
doi:10.1371/journal.pone.0156480.t001
Table 2. Annealing temperature and sequences of the primers.
Target Annealing Temperature forward 5´-3´ backward 5´-3´
β-actin 59°C agccatgtacgtagccatcc accctcatagatgggcacag
GAPDH 59°C tgccactcagaagactgtgg ttcagctctgggatgacctt
TGF-β1 61°C gtcaactgtggagcaacacg agacagccactcaggcgtat
IL-17 60°C actttccgggtggagaagat cttaggggctagcctcaggt
IL-6 60°C accacccacaacagaccagt cagaattgccattgcacaac
doi:10.1371/journal.pone.0156480.t002
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(5 min in 100% ethanol at -20°C and 2 min in 100% acetone at -20°C), blocked using HEPES/
BSA-buffer (20 mMHEPES, 1% BSA in PBS) and incubated with specific goat anti-rat IL-17
(Santa Cruz, Heidelberg, Germany) and/or rabbit- anti rat TGF-β1 antibody (Santa Cruz, Hei-
delberg, Germany) for 60 min at 37°C, followed by four 5 min washings with HEPES-buffer
(20 mMHEPES in PBS). Finally, cells were incubated with a secondary fluorochrome-conju-
gated antibody (AlexaFluor 568 goat anti-rabbit IgG (H+L) for TGF-β1; donkey anti-goat IgG
(H+L) for IL-17), washed again and nuclear stained with DAPI for 30 s, washed 3 times for 5
min each and then covered with Fluoromount-G (Southern Biotech, Birmingham, USA).
Statistical analysis. Results are expressed as mean +/- standard error of the mean. For sta-
tistical comparison, p values were calculated with Student´s t-test, and p<0.05 was considered
as significant.
Results
Disease course of acute anti-thy1 glomerulonephritis
24h after disease induction proteinuria decreases slightly (40mg ± 2mg/24h). Proteinuria was
maximally increased five days after disease induction (113 ± 13 mg/24h vs. con 29 ± 3 mg/24h,
p<0.001) and declined thereafter towards normal levels (d10 82 ± 17 mg/24h, d15 63 ± 13 mg/
24h, d20 47 ± 5 mg/24h; see Fig 1). Fig 2A shows characteristic histological photographs of glo-
merular changes. In the matrix expansion phase a considerable histological matrix accumula-
tion was found (d5 82 ± 7% vs. con 29 ± 2%, p<0.001; d10 78 ± 8%, p<0.001), with a decline in
the subsequent matrix resolution phase (d15 58 ± 8%, p<0.001, d20 44 ± 4%, p<0.01) (Fig 2B).
Glomerular TGF-β1, IL-6 and IL-17 mRNA expression
No significantly increase in TGF-β1, IL-6 and IL-17 mRNA expression were found 24h after
disease induction. IL-17 mRNA expression was significantly increased by 6.5-fold (p<0.05) on
d5, which gradually decreased to 1.9-fold (p<0.05) on d20. TGF-β1 mRNA expression was
maximally elevated on d5 by 2.2-fold (p<0.05), whereas it was found to be reduced to 0.33-fold
on d10 (p<0.05), 0.19-fold on d15 (0.19 fold con; p<0.05) and 0.28-fold on d20 (p<0.05)
when compared to normal controls. IL-6 mRNA expression was at a maximum on d5 (36-fold
increase; p<0.05) and had a similarly lower expression on d10 (0.41-fold), d15 (0.71-fold) and
d20 (0.25-fold; p<0.05) in comparison with the control animals (Fig 3).
IL-17 protein expression in acute anti-thy1 glomerulonephritis
In line with the mRNA data, immunostaining demonstrated a considerable increase of IL-17
protein on d5 and a gradual decline thereafter (Fig 4). In order to identify the cellular source of
IL-17 expression, classical APAAP immunostaining as well as in situ hybridization was per-
formed. IL-17 protein and mRNA were seen to be stained in endothelial cells of d5 nephritic
glomeruli, as indicated by the black arrows in Fig 5A (protein) and 5B (mRNA). This was con-
firmed by double staining. The endothelial cell marker PECAM-1 co-localized with IL-17
staining in glomerular cells on day 5 after induction of acute anti-thy1 glomerulonephritis, as
indicated by the yellow merge in Fig 6, while there was no merge with the mesangial cell
marker OX-7 or the podocyte cell marker synaptopodin (Fig 7).
NRK-52E cells as an in vitro model to analyze TGF-β1, IL-6 and IL-17
interaction
NRK-52E cell line express low levels of TGF-β1, IL-6 and IL-17 mRNA under basal conditions
(Fig 8). The exposure to 25 mM glucose (high glucose, HG) as an injury stimulus significantly
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enhanced simultaneously TGF-β1 by 2.2-fold (p<0.01; 30 min), IL-6 mRNA by 13.1-fold;
p<0.001; 30 min) and IL-17 mRNA by 7.6-fold; (p<0.001) 30 min after stimulation. In the
presence of 20 mMmannose and 5 mM glucose as a comparable osmotic control, no signifi-
cant changes were found in TGF-β1, IL-6 and IL-17 mRNA expression.
TGF-β1/ IL-6 co-administration synergistically induces IL-17 mRNA
expression in NRK-52E cells
TGF-β1 as the key mediator of fibrosis and the classic proinflammatory cytokine IL-6 are
known to synergistically induce CD4+ cells to develop into TH17 via activation of the STAT3/
RORγt pathway. To analyze this interaction in renal cells, NRK-52E cells were co-stimulated
by TGF-β1 (5 ng/ml) and IL-6 (10 ng/ml). See Fig 9. Dual stimulation led to a high synergistical
enhancement of IL-17 mRNA expression in NRK-52E by 4986-fold (p<0.001). In parallel, an
Fig 1. Proteinuria over the time course of acute anti-thy1 glomerulonephritis. The disease was induced by a single OX-7 antibody injection. Control
animals received the same volume of PBS. Animals were housed in metabolic cages, urine was collected for 24 h and proteinuria was measured by a
modified pyrogallol red method 24h = animals after 24 hours after aGN induction, d5 = animals on day 5 after aGN induction, d10 = animals on day 10
after aGN induction, d15 = animals on day 15 after aGN induction, d20 = animals on day 20 after aGN induction are shown. (# p< 0.001 vs. con; *p<0.05
vs. d5).
doi:10.1371/journal.pone.0156480.g001
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up-regulation of TGF-β1 mRNA by 216-fold (p<0.01) and IL-6 mRNA by 3312-fold (p<0.01)
in NRK-52E within 15 min was observed. In the doses employed in this study, no effective cell
death was observed as analyzed by MTT vitality and BrdU proliferation testing (data not
shown). The rather moderate effect of single factor expose (high glucose, TGF-β1, IL-6 and IL-
17) on the mRNA expression of the corresponding cytokines is shown in Fig 10. That the syn-
ergistic action of TGF-β1/ IL-6 co-administration on IL-17 mRNA expression is at a maximum
at 15 min and decreases thereafter was depicted in Fig 9.
Fig 2. (A) PAS-stained tissue sections over the time course of acute anti-thy1 glomerulonephritis
(aGN).Representative pictures of periodic acid-Schiff (PAS) stainings of kidneys tissue sections from con
(PBS-injected control) animals, 24h = animals after 24 hours after aGN induction, d5 = animals on day 5 after
aGN induction, d10 = animals on day 10 after aGN induction, d15 = animals on day 15 after aGN induction,
d20 = animals on day 20 after aGN induction are shown. Magnification here is x400. (B) PAS-stained kidney
sections were scored. (# p< 0.001 vs.d5; * p<0.001 vs. con).
doi:10.1371/journal.pone.0156480.g002
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Fig 3. Glomerular mRNA expression of IL-6, TGF-β1 and IL-17 over the time course of acute anti-thy1
glomerulonephritis (aGN). The disease was induced by a single OX-7 antibody injection. Control animals
(con) received the same volume of PBS. Animals were sacrificed, glomeruli were harvested and graded
using the sieving technique and mRNA was isolated using TRIZOL reagent. After reverse transcription
mRNA, expression levels were measured by real time PCR. For analysis, the relative quantification ΔΔCP
method was used. (# p<0.05 vs. con).
doi:10.1371/journal.pone.0156480.g003
IL-17 in Acute Anti-Thy1 Glomerulonephritis
PLOS ONE | DOI:10.1371/journal.pone.0156480 May 31, 2016 8 / 19
TGF-β receptor kinase inhibition abolishes IL-17 expression
We next investigated TGF-β1 and IL-17 protein expression in NRK-52E cells by immunofluo-
rescence staining. NRK-52E cells show an up-regulation in TGF-β1 and IL-17 protein expres-
sion after exposure to 25 mM glucose. Furthermore, one single stimulation with 5 ng/ml of
TGF-β1 or 25 ng/ml IL-17 resulted in an auto-induction of both cytokines. Similar to the
mRNA results above, a synergistic action on IL-17 protein expression was also found when the
cells were co-incubated with 5 ng/ml TGF-β1 and 10 ng/ml IL-6 (Fig 11). When the cells were
exposed to SB 431542 (at 10 μM a specific inhibitor of the TGF-β superfamily activin receptor-
like kinase (ALK)), the expressions of both TGF-β1 and IL-17 were largely lost after stimula-
tion using high glucose, TGF-β1 and TGF-β1/ IL-6 co-stimulation.
Discussion
The present study documents a time-dependent expression of the new pro-inflammatory cyto-
kine IL-17 in renal endothelial cells during the course of acute anti-thy1 glomerulonephritis.
Furthermore, parallel renal cell culture stimulation and inhibition experiments suggest a
Fig 4. Immunostained tissue sections over the time course of acute anti-thy1 glomerulonephritis (aGN). Representative pictures showing IL-
17-immunostained kidneys from con (PBS-injected control) animals, d5 = animals on d5 after aGN induction, d10 = animals on day 10 after aGN
induction, d15 = animals on day 15 after aGN induction and nc = negative control are shown. IL-17 red, nucleus blue (magnification x 400).
doi:10.1371/journal.pone.0156480.g004
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synergism of TGF-β1 and IL-6 in IL-17 up-regulation, and a TGF-β1/ IL-17 network which is
operative in resident renal cells.
The important role of IL-17 and TH17 cells in inflammatory processes has been recognized
over the last few years. The pro-inflammatory cytokine IL-17 is a member of a new cytokine
family which shows only few or even no homologies with other interleukins [37] and is
expressed by activated Th17 cells, which are important mediators of autoimmune response
[23,38]. Most experimental evidence to date suggests a role of IL-17 in coordinating local tissue
inflammation via induced release of pro-inflammatory and granulocyte mobilizing cytokines.
In 2007, Cortez et al. first found that non-immune cells such as cardiac fibroblasts are able to
secrete IL-17 [39]. IL-17 receptors are expressed ubiquitously, suggesting the ability of IL-17 to
operate via autocrine and paracrine mechanisms. Recently, IL-17-producing Th17 cells were
identified to be involved in kidney inflammation [40,41]. Additionally, Loverre et al. showed
IL-17 expression by tubular endothelial cells in renal transplant during acute antibody-medi-
ated rejection [31]. A large number of recent studies has established a central role of the profi-
brotic cytokine TGF-β1 and the proinflammatory cytokine IL-6 for TH17 cell differentiation
and secretion of IL-17 [26,27,42] and shown that both are markedly involved in pathogeneses
of acute and chronic kidney disease. Thus, we addressed the question of a TGF- β1/ IL-6/ IL-17
network in resident renal cells. To investigate IL-17 expression in renal cells over the time
course of acute glomerulonephritis, a model of acute anti-thy1 glomerulonephritis in rats was
used. Due to a single OX-7 antibody injection, a temporary complement and NO-mediated
mesangial cell lysis occurred [43]. The model used resembles to some extent human IgA-
nephropathy [33] and shows marked acute extracellular matrix expansion. Acute anti-thy1
glomerulonephritis in the rat is characterized by an injury phase (6–48 h after induction) with
mesangial cell lysis, macrophage influx, and overexpression of proinflammatory cytokines such
as TNF-α and IL-1. Followed by matrix expansion phase (d5 to d12) with increased mesangial
cell proliferation, extracellular matrix expansion, and micro-aneurysm in glomerular capillar-
ies, overexpression of profibrotic cytokines (TGF-β1, activin A) and matrix proteins (collagen
Fig 5. Glomerular protein expression and in situ hybridization of IL-17mRNA of anti-thy1 glomerulonephritic animals on d5.Representative
images showing glomerular protein expression (A) and in situ hybridization (B) of IL-17 mRNA (dark purple) of anti-thy1 glomerulonephritic animals on d5
after disease induction, in paraffin-embedded renal sections at x400 magnification. The black arrows indicate IL-17protein or mRNA deposition.
doi:10.1371/journal.pone.0156480.g005
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and fibronectin) took place. The molecular mechanism of extracellular matrix expansion is
similar to the mechanism in diabetic [44] and hypertensive nephropathy [45].
The cytokine TGF-β1 is a key mediator during of extracellular matrix expansion and kidney
fibrosis formation. Findings by Border and Noble with overexpression of TGF-β1 in renal
fibrosis and successful use of neutralizing anti-TGF-β1 antibody demonstrated that the cyto-
kine TGF-β1 plays as a major role in kidney fibrosis during acute anti-thy1 glomerulonephritis
[5]. The present study documents a high up-regulation of TGF-β1 protein and mRNA expres-
sion with the highest peak seen on d5 (matrix expansion phase), which then declines over the
following days. Furthermore, we found an up-regulation of the pro-inflammatory cytokine
Fig 6. IL-17 and PECAM-1 protein expression of an anti-thy1 glomerulonephritic animal on d5. Representative images showing glomerular IL-17
and PECAM-1 protein expression in renal tissue sections of an anti-thy1 glomerulonephritic animal on d5 after disease induction, in paraffin-embedded
immunostained sections at x400 magnification. IL-17 green, PCAM-1 red, nucleus blue, merge yellow.
doi:10.1371/journal.pone.0156480.g006
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IL-6 on d5 of acute anti-thy1 glomerulonephritis, confirming recent experimental studies
which demonstrated convincingly that IL-6 is a strong mediator of mesangial cell proliferation
and matrix expansion in glomerulonephritis [46–48].
We speculate that the considerable up-regulation of IL-17 expression on d5, as seen at the
mRNA and protein levels, is a result of TGF-β1 and IL-6 up-regulation. To our knowledge this
is the first time a significant increase of IL-17 mRNA and protein in acute anti-thy1 glomerulo-
nephritis has been detected. Our findings—that TGF-β1, IL-6 and IL-17 are coordinately up-
regulated in the matrix expansion phase—provide strong evidence for an interaction in the
genesis of acute glomerulonephritis.
Fig 7. IL-17 and synaptopodin protein expression of an anti-thy1 glomerulonephritic animal on d5. Representative images showing glomerular IL-
17 and synaptopodin protein expression in renal tissue sections of an anti-thy1 glomerulonephritic animal on d5 after disease induction, in paraffin-
embedded immunostained sections at x400 magnification. IL-17 green, synaptopodin red, nucleus blue, merge yellow.
doi:10.1371/journal.pone.0156480.g007
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We also showed by double staining analyses that the increased IL-17 expression found on
day 5 is unique for renal endothelial cells. No merge in other resident renal cells (e.g. podocytes,
mesangial cells) was observed. Various renal cells (mesangial cells, tubular epithelial cells,
fibroblast, podocytes), non-renal cells (lymphocytes, macrophages, thrombocytes) and
Fig 8. TGF-β1, IL-6 and IL-17 mRNA expression of NRK-52E after glucose stimulation. Relative TGF-β1
(A), IL-6 (B) and IL-17 (C) mRNA expression of non-stimulated NRK-52E (nc) and at different time points after
stimulation by 25 mM glucose or 20 mMmannose as an osmotic control. Analysis utilized real-time PCR and
was normalized to β-actin as housekeeping gene. (# p <0.05 vs. nc; * p<0.001 vs. nc).
doi:10.1371/journal.pone.0156480.g008
IL-17 in Acute Anti-Thy1 Glomerulonephritis
PLOS ONE | DOI:10.1371/journal.pone.0156480 May 31, 2016 13 / 19
systemic factors like hemodynamic entities are involved in the development of acute and
chronic glomerulonephritis. Due to this, today's investigations of interactions in cytokine net-
working have clearly become a challenging event. Therefore TGF-β1/ IL-17 interaction was
examined using in vitro experiments, since conditions and influence of known and unknown
Fig 9. TGF-β1, IL-6 and IL-17 mRNA expression of NRK-52E after co-stimulation by TGF-β1 and IL-6.
Relative TGF-β1 (A), IL-6 (B) and IL-17 (C) mRNA expression of non-stimulated NRK-52E (nc) and at
different time points after co-stimulation by 5 ng/ml TGF- β1 and 10 ng/ml IL-6. Analysis utilized real-time
PCR and was normalized to β-actin as housekeeping gene. (# p <0.05 vs. nc; * p<0.001 vs. nc).
doi:10.1371/journal.pone.0156480.g009
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biological parameters can be standardized. In 2007, Cortez et al. presented for the first time
data which demonstrate that non-immune, non-endothelial cells, i. e. cardiac fibroblasts, have
an ability to express low levels of IL-17 [39]. We choose for our in vitro the well established
renal tubular epithelial cell line, NRK-52E. In pilot experiments, we had found reproducible
IL-17 mRNA and protein expression by TGF-β and IL-6. Other groups had employed NRK-
52E for pathomechanism involved in glomerular alterations [49]. Subsequently Venkatachalam
et al. showed that stimulation of primary mouse cardiac fibroblasts by high glucose levels
(25 mM) induces increased IL-17 expression via PI3K!Akt!ERK signaling that was abol-
ished by PI3K inhibition via resveratrol [50]. Since high glucose concentrations can act as an
unspecific injury stimulus and thus no further cytokine like TNF-α is required, we simply used
a high glucose concentration as a stimulation in our investigations. Venkatachalam's finding is
in a line with our investigations of time-dependent IL-17 expression increase in NRK-52E cells
after a high glucose stimulation. We found a significantly increased IL-17 mRNA and protein
expression in renal tubular epithelial cells by synergistic TGF-β1 and IL-6 stimulation, suggest-
ing a regulatory connection between these. Wu and Derynck showed that glucose stimulation
induces TGF-β1 expression via c-terminal phosphorylation of Smad 3, similar to activation in
response to TGF-β1 and glucose induces nuclear translocation of Smad2/3 as well as
PI3K!Akt!mTOR activation are blocked by SB421542 [51]. However our data indicate that
Fig 10. TGF-β1, IL-6 and IL-17mRNA expression of NRK-52E after glucose, IL-6, TGF-β1 or IL-17 stimulation. TGF-β1, IL-6 and IL-17 mRNA
expression in NRK-52E cells 15 min after stimulation by 25 mM glucose, 10 ng/ml IL-6, 5 ng/ml TGF-β1 or 25 ng/ml IL-17. Analysis utilized real-time PCR
and was normalized to β-actin as housekeeping gene. (# p <0.05 vs. nc; * p<0.01 vs. nc).
doi:10.1371/journal.pone.0156480.g010
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there may in fact be a regulatory key mechanism in the TGF-β1/ IL-17 network of resident
renal cells, since TGF-β receptor antagonism in vitro by selective TGF-β receptor type 1 block-
ade using SB431542 down-regulates IL-17 expression. We found an abolishment of IL-17
expression by SB431542 treatment after IL-17 auto-induction, induction by TGF-β1/ IL-6 co-
stimulation, as well as unspecific injury stimulation by high glucose contents. In 2008, Nardelli
et al. showed a similar effect in experimental destructive arthritis in mice. They found that co-
treatment with anti-TGF-β1, anti-IL-6 and anti-IL-17 antibody reduced the severity of arthritis
significantly more than the inhibition of single cytokines in Borellia-vaccinated and challenged
mice did [52]. This underlines the imperative usage of a TGF-β RI kinase activity for these
effects. This finding suggest that the key cytokines TGF-β1 and IL-6 work together with IL-17
during acute anti-thy1 glomerulonephritis and a potential therapy may aim at a concerted inhi-
bition of these cytokines.
Conclusions
Our study documents a time-dependent expression of the pro-inflammatory cytokine IL-17 in
renal endothelial cells in acute anti-thy1 glomerulonephritis. In vitro, NRK-52E cells secrete
IL-17 under pro-fibrotic and pro-inflammatory conditions. This result indicates that IL-17 is
part of the link between inflammation and fibrosis, and is involved in the in the pathogenesis
of acute glomerulonephritis.
Fig 11. Immunofluorescence of NRK-52E after stimulation. Representative images showing IL-17 (red) and TGF-β1 (green) expression, merge
(yellow), nucleus (blue) of NRK-52E cells. Row one shows untreated NRK-52E cells, NRK-52E cells stimulated by 25 mM glucose (high glucose), 5 ng/ml
TGF-β1, 25 ng/ml IL-17, 5 ng/ml TGF-β1+ 10 ng/ml IL-6. Row two depicts TGF-β1 and IL-17 expression in NRK-52E after treatment by 10 μM TGF-β
receptor blocker SB431542 after stimulation by 25 mM glucose (high glucose), 5 ng/ml TGF-β1, 25 ng/ml IL-17, 5ng/ml TGF-β1+ 10 ng/ml IL-6. All cells
are starved 24 h for cell cycle synchronization and stimulated for 48 h at 37°C under 5% CO2 and then immune-stained (magnification x1000).
doi:10.1371/journal.pone.0156480.g011
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